Literature DB >> 6858899

Altered baroreceptor function in children with systolic hypertension after coarctation repair.

R H Beekman, B P Katz, C Moorehead-Steffens, A P Rocchini.   

Abstract

To determine whether altered baroreceptor function may contribute to systemic hypertension after coarctation of the aorta (C of A) repair, baroreceptor function was evaluated in 6 children with repaired C of A mild arm systolic hypertension. Data were compared with those from 7 normotensive control children with hemodynamically mild heart disease. Age at C of A repair averaged 9.9 +/- 3.1 years (mean +/- standard deviation [SD]). Arm systolic pressure was 143.8 +/- 2.9 mm Hg in the C of A repair group, compared with 118.3 +/- 9.9 for control subjects (p less than 0.001). At catheterization, steady-state sigmoidal baroreceptor function curves relating mean arterial pressure to R-R interval were derived by increasing and decreasing mean arterial pressure with small injections of phenylephrine and nitroprusside. Compared with control subjects, the baroreceptor function curves of children with repaired C of A (1) are reset about a higher baseline mean arterial pressure (108.8 +/- 6.6 versus 90.3 +/- 8.6 mm Hg, p less than 0.01), (2) have a decreased slope (7.9 +/- 3.7 versus 17.4 +/- 3.6 ms/mm Hg, p less than 0.001), and (3) have a diminished R-R interval range (246.7 +/- 81.5 versus 535.7 +/- 97.2 ms, p less than 0.001). Thus, in children with hypertension after C of A repair, the baroreflex is reset to an elevated mean arterial pressure level and has a diminished sensitivity to changes in arterial pressure.

Entities:  

Mesh:

Year:  1983        PMID: 6858899     DOI: 10.1016/0002-9149(83)90080-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  16 in total

1.  Exercise testing is useful to screen for residual coarctation in children.

Authors:  Bibhuti B Das; Shashi Raj; Lawrence Shoemaker
Journal:  Pediatr Cardiol       Date:  2009-05-16       Impact factor: 1.655

2.  Blood pressure evaluation in children treated with laser surgery for twin-twin transfusion syndrome at 2-year follow-up.

Authors:  Jay D Pruetz; Sheree M Schrager; Tiffany V Wang; Arlyn Llanes; Ramen H Chmait; Douglas L Vanderbilt
Journal:  Am J Obstet Gynecol       Date:  2015-05-21       Impact factor: 8.661

3.  Coarctation of the aorta associated with Dandy-Walker variant.

Authors:  Li Zhou; George K Lui; Rajesh Shenoy; Cynthia C Taub
Journal:  J Cardiovasc Dis Res       Date:  2013-08-20

Review 4.  Metabolic syndrome and coronary artery disease in adults with congenital heart disease.

Authors:  Koichiro Niwa
Journal:  Cardiovasc Diagn Ther       Date:  2021-04

Review 5.  Hypertension in Coarctation of the Aorta: Challenges in Diagnosis in Children.

Authors:  Trisha V Vigneswaran; Manish D Sinha; Israel Valverde; John M Simpson; Marietta Charakida
Journal:  Pediatr Cardiol       Date:  2017-10-17       Impact factor: 1.655

6.  Aortic coarctation: the need for lifelong surveillance.

Authors:  J W J Vriend; B J M Mulder
Journal:  Neth Heart J       Date:  2003-12       Impact factor: 2.380

7.  Resetting of the cardiopulmonary baroreflex 10 years after surgical repair of coarctation of the aorta.

Authors:  D Johnson; H Perrault; S J Vobecky; F Trudeau; E Delvin; A Fournier; A Davignon
Journal:  Heart       Date:  2001-03       Impact factor: 5.994

8.  Atrial Functions and Aortic Elasticity in Children with Aortic Coarctation.

Authors:  Savas Demirpence; Baris Guven; Murat Muhtar Yilmazer; Taliha Oner; Onder Doksoz; Timur Mese; Vedide Tavli
Journal:  Acta Cardiol Sin       Date:  2015-05       Impact factor: 2.672

9.  Intravenous nicardipine for treatment of postcoarctectomy hypertension in children.

Authors:  T A Nakagawa; S C Sartori; A Morris; D S Schneider
Journal:  Pediatr Cardiol       Date:  2003-10-13       Impact factor: 1.655

10.  Ambulatory blood pressure in patients with occult recurrent coarctation of the aorta.

Authors:  M D Parrish; E Torres; R Peshock; D E Fixler
Journal:  Pediatr Cardiol       Date:  1995 Jul-Aug       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.